Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apyx Medical Corp (APYX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Apyx Medical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 719135.
Total stock buying since 2015: $704,762.
Total stock sales since 2015: $113,400.
Total stock option exercises since 2015: $543,419.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 12,000 | $21,600 |
| 2024 | 5,336 | $6,029 | 0 | $0 | 0 | $0 |
| 2023 | 52,500 | $83,975 | 15,000 | $113,400 | 30,338 | $70,303 |
| 2022 | 11,750 | $69,912 | 0 | $0 | 126,173 | $414,809 |
| 2021 | 0 | $0 | 0 | $0 | 13,063 | $36,707 |
| 2020 | 28,250 | $93,196 | 0 | $0 | 0 | $0 |
| 2016 | 90,750 | $299,475 | 0 | $0 | 0 | $0 |
| 2015 | 75,000 | $152,175 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-01 | 0 | $0 | 0 | $0 | 12,000 | $21,600 |
| 2024-08 | 5,336 | $6,029 | 0 | $0 | 0 | $0 |
| 2023-12 | 2,500 | $5,475 | 0 | $0 | 0 | $0 |
| 2023-11 | 50,000 | $78,500 | 0 | $0 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 5,338 | $15,853 |
| 2023-06 | 0 | $0 | 15,000 | $113,400 | 25,000 | $54,450 |
| 2022-08 | 11,750 | $69,912 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 88,000 | $223,520 |
| 2022-05 | 0 | $0 | 0 | $0 | 14,000 | $39,060 |
| 2022-03 | 0 | $0 | 0 | $0 | 17,000 | $84,660 |
| 2022-01 | 0 | $0 | 0 | $0 | 7,173 | $67,569 |
| 2021-03 | 0 | $0 | 0 | $0 | 13,063 | $36,707 |
| 2020-05 | 28,250 | $93,196 | 0 | $0 | 0 | $0 |
| 2016-08 | 90,750 | $299,475 | 0 | $0 | 0 | $0 |
| 2015-12 | 55,000 | $104,375 | 0 | $0 | 0 | $0 |
| 2015-08 | 20,000 | $47,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-27 | Roman Shawn David (Chief Operating Officer) | Option Ex | 12,000 | 1.80 | 21,600 |
| 2024-08-13 | Hill Matthew C (Chief Financial Officer) | Buy | 5,336 | 1.13 | 6,029 |
| 2023-12-12 | Hill Matthew C (Chief Financial Officer) | Buy | 2,500 | 2.19 | 5,475 |
| 2023-11-14 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 50,000 | 1.57 | 78,500 |
| 2023-07-12 | Waldman Lawrence | Option Ex | 5,338 | 2.97 | 15,853 |
| 2023-06-26 | Hornsby Todd (Executive Vice President) | Sale | 15,000 | 7.56 | 113,400 |
| 2023-06-26 | Hornsby Todd (Executive Vice President) | Option Ex | 15,000 | 1.77 | 26,550 |
| 2023-06-06 | Geraghty Michael (Director) | Option Ex | 10,000 | 2.79 | 27,900 |
| 2022-08-29 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 11,750 | 5.95 | 69,912 |
| 2022-07-11 | Waldman Lawrence | Option Ex | 24,000 | 2.54 | 60,960 |
| 2022-07-11 | Citronowicz Moshe (Sr. V.P. of Operations) | Option Ex | 30,000 | 2.54 | 76,200 |
| 2022-07-06 | Geraghty Michael | Option Ex | 4,000 | 2.54 | 10,160 |
| 2022-07-05 | Makrides Andrew | Option Ex | 30,000 | 2.54 | 76,200 |
| 2022-05-19 | Waldman Lawrence | Option Ex | 8,000 | 2.79 | 22,320 |
| 2022-05-11 | Geraghty Michael | Option Ex | 6,000 | 2.79 | 16,740 |
| 2022-03-21 | Swandal Craig A. | Option Ex | 17,000 | 4.98 | 84,660 |
| 2022-01-07 | Swandal Craig A. | Option Ex | 7,173 | 9.42 | 67,569 |
| 2021-03-08 | Waldman Lawrence | Option Ex | 5,563 | 2.81 | 15,632 |
| 2021-03-05 | Geraghty Michael | Option Ex | 7,500 | 2.81 | 21,075 |
| 2020-05-13 | Goodwin Charles D. Ii (Chief Executive Officer) | Buy | 28,250 | 3.30 | 93,196 |
| 2016-08-17 | Mccarthy John J. Iii (Chief CommercializationOfficer) | Buy | 90,750 | 3.30 | 299,475 |
| 2015-12-22 | Mccarthy John J. Iii (Chief Commercialization Office) | Buy | 25,000 | 1.98 | 49,425 |
| 2015-12-21 | Gershon Robert (Chief Executive Officer) | Buy | 10,000 | 1.82 | 18,170 |
| 2015-12-21 | Citronowicz Moshe (Sr. V.P. of Operations) | Buy | 20,000 | 1.84 | 36,780 |
| 2015-08-01 | Gershon Robert (Chief Executive Officer) | Buy | 20,000 | 2.39 | 47,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of APYX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Apyx Medical Corp (symbol APYX, CIK number 719135) see the Securities and Exchange Commission (SEC) website.